Buddy Roemer: Me, O...
Health Care: Health Services
Enzo Biochem Inc. (ENZ: NYSE)
$2.93 0.04 | 1.38%
02/08/12 - 04:00 PM ET
120.41K / 150.80K
Vol / Avg. Vol:2.89 / 2.89
Open / Prev. Close:2.82 - 2.95
Today's Range:1.98 - 5.00
52 Wk Range:30.80%
Performance YTD:TheStreet Rating:
Portfolios with ENZ
- Portfolio NameUser Type
- UserBarron's Insider Purchases ...
- ContributorStockerblog.com Gene Therap...
- Userkelvinenz Portfolio 1
- UserS-0022
- UserTraderSteveUK Portfolio 1
- UserRT_in_CA
- ProTA IDEX Evergreen Health Ca...
- UserSo far, I'm beating the S&a...
- Userjwcarmack Portfolio 1
- Userrecentoutperform070824
Latest ENZ Headlines from TheStreet
- Thursday Earnings Live Blog 10.14.10 | 04:10 pm
- Investors May See Upside Down Under 09.16.10 | 08:09 am
- Enzo Biochem 1Q Loss Narrows On Revenue Boost 12.10.09 | 04:12 pm
- Enzo Biochem 4Q Loss Widens On Costs 10.14.09 | 06:10 pm
- Tuesday's Health Winners & Losers 10.16.07 | 04:10 pm
- Enzo Biochem Falls on Court Dismissal 09.07.07 | 02:09 pm
- Friday's Health Winners & Losers 09.07.07 | 02:09 pm
- Checking Up on Biotech 08.10.07 | 04:08 pm
- Monday's Health Winners & Losers 10.16.06 | 02:10 pm
- Enzo Biochem Loss Widens 10.16.06 | 11:10 am
Press Releases for ENZ
- Enzo Biochem Schedules Teleconference To Discuss 2012 First Quarter Results On December 13, 2011 At 8:30 AM E.T. - Business Wire 12.07.11 | 02:12 pm
- Enzo Biochem To Present At Lazard Capital Markets 8th Annual Healthcare Conference - Business Wire 11.09.11 | 08:11 am
- Enzo Reports Record Revenues Of $102 Million For Fiscal Year 2011 - Business Wire 10.14.11 | 04:10 pm
- Enzo Biochem Schedules Teleconference To Discuss 2011 Fourth Quarter And Year-End Results On October 17, 2011, At 8:30 AM E.T. - Business Wire 10.12.11 | 02:10 pm
- Enzo Biochem To Present At Rodman & Renshaw Thirteenth Annual Healthcare Conference - Business Wire 09.08.11 | 11:09 am
- Enzo Biochem Appoints Four Executives At Enzo Life Sciences As Unit Adds Products And Platforms To More Aggressively Expand In Pharmaceutical And Clinical Markets - Business Wire 08.22.11 | 10:08 am
- Enzo Scientists Report On Key Discovery Of Novel Targets For Metabolic Bone Disease And Other Conditions - Business Wire 07.06.11 | 08:07 am
- U.S. Supreme Court Declines Life Technologies Appeal Hearing In Patent Infringement Suit Brought By Enzo Biochem Claiming Substantial Damages - Business Wire 06.21.11 | 11:06 am
- Enzo Biochem’s Clinical Lab Acquires Marketing Rights To Unique, More Effective Diagnostic Test For Cervical Cancer - Business Wire 06.10.11 | 07:06 am
- Enzo Biochem Reports Improved Third Quarter Results - Business Wire 06.09.11 | 04:06 pm
Partner Headlines for ENZ
- Enzo Biochem: Personalized Medicine Is More Than Targeted Therapeutics - Seeking Alpha 04.03.11 | 07:04 am
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? - Seeking Alpha 08.25.10 | 09:08 am
- Top 5 Percentage Gainers On NYSE (DV, CKH, ENZ, LAD, CMG) - Benzinga 07.23.10 | 03:07 pm
- MB FINANCL INC (MBFI) - Profit Tracks - Zacks 04.13.10 | 01:04 am
- UPDATE 2-Enzo wins round in Applera patent fight - Reuters 03.26.10 | 04:03 pm
